Study of the Osteoprotector Effects of a Milk Product Based on Anthocyans and Enriched in Calcium and Vitamin D
Phase 2
Completed
- Conditions
- Osteoporosis
- Registration Number
- NCT00663221
- Lead Sponsor
- Elvir SAS
- Brief Summary
We hypothesize that anthocyans with calcium and vitamin D have a positive effect on bone reshaping in menopausal women.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 56
Inclusion Criteria
- Women
- Aged between 50 and 65 years
- Between 1 and 5 years menopause
- IMC between 19 and 30 kg/m²
Exclusion Criteria
- Medical Treatment for bone metabolism
- Vitamin D not including in the range of 20nmoles<25(OH)<100nmoles/l
- Vegan and vegetarian diet
- Regular consumption of food supplementary benefits
- Lactose intolerance
- While dieting
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie anthocyan-induced bone remodeling in postmenopausal osteoporosis?
How does anthocyan supplementation compare to bisphosphonates in improving BMD in menopausal women?
Which biomarkers correlate with response to anthocyan, calcium, and vitamin D combination therapy in osteoporosis?
What are the safety profiles of anthocyan-rich dietary supplements in long-term osteoporosis management?
Are there synergistic effects of anthocyan with RANKL inhibitors in preventing bone resorption in postmenopausal patients?
Trial Locations
- Locations (1)
CHU Clermont-Ferrand
🇫🇷Clermont-Ferrand, France
CHU Clermont-Ferrand🇫🇷Clermont-Ferrand, France